Christopher D. Sveen - 28 Feb 2022 Form 4 Insider Report for HESKA CORP

Reporting relationship: CAO & General Counsel
Issuer ticker: N/A
Reported as of: 28 Feb 2022
Net transaction value: -$3,310,920
SEC form: 4
Accepted by SEC: 14 Jun 2023, 18:27:25 UTC
Prior SEC filing: 28 Sep 2021
Next SEC filing: 26 Sep 2022
Source filing: View source filing
Reporting owner signature: /s/ Catherine Grassman For: Christopher Sveen

Key filing fact

Christopher D. Sveen filed Form 4 for HESKA CORP on 14 Jun 2023.

Key facts

This page summarizes Christopher D. Sveen's Form 4 filing for HESKA CORP.
11 reported transactions and 8 derivative rows are listed below.
Accepted by SEC: 14 Jun 2023, 18:27.

Change

Previous filing in this sequence was filed on 28 Sep 2021.
Current net transaction value: -$3,310,920.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HSKA transaction

Common Stock

Award

Transaction value: $0
Shares: +15,157
Change %: +179%
Price: $0.000000
Shares after: 23,643
Date: 13 Jun 2023
Ownership: Direct
Footnotes: F1

HSKA transaction

Common Stock

Award

Transaction value: $0
Shares: +3,948
Change %: +17%
Price: $0.000000
Shares after: 27,591
Date: 13 Jun 2023
Ownership: Direct
Footnotes: F2

HSKA transaction

Common Stock

Disposed to Issuer

Transaction value: $3,310,920
Shares: -27,591
Change %: -100%
Price: $120.00
Shares after: 0
Date: 13 Jun 2023
Ownership: Direct
Footnotes: F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HSKA transaction Derivative

Performance Shares

Disposed to Issuer

Transaction value
Shares: -750
Change %: -100%
Price
Shares after: 0
Date: 13 Jun 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 750
Exercise price
Footnotes: F4, F5

HSKA transaction Derivative

Non-Qualified Stock Option (right to buy)

Award

Transaction value: $0
Shares: +10,000
Change %
Price: $0.000000
Shares after: 10,000
Date: 28 Feb 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 10,000
Exercise price: $60.94
Footnotes: F6

HSKA transaction Derivative

Non-Qualified Stock Option (right to buy)

Award

Transaction value: $0
Shares: +25,000
Change %: +250%
Price: $0.000000
Shares after: 35,000
Date: 13 Jun 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 25,000
Exercise price: $60.94
Footnotes: F7

HSKA transaction Derivative

Non-Qualified Stock Option (right to buy)

Disposed to Issuer

Transaction value
Shares: -35,000
Change %: -100%
Price
Shares after: 0
Date: 13 Jun 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 35,000
Exercise price: $60.94
Footnotes: F6, F7, F8

HSKA transaction Derivative

Incentive Stock Option (right to buy)

Disposed to Issuer

Transaction value
Shares: -2
Change %: -100%
Price
Shares after: 0
Date: 13 Jun 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2
Exercise price: $60.94
Footnotes: F8, F9

HSKA transaction Derivative

Non-Qualified Stock Option (right to buy)

Disposed to Issuer

Transaction value
Shares: -9,998
Change %: -100%
Price
Shares after: 0
Date: 13 Jun 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 9,998
Exercise price: $60.94
Footnotes: F8, F9

HSKA transaction Derivative

Incentive Stock Option (right to buy)

Disposed to Issuer

Transaction value
Shares: -4,173
Change %: -100%
Price
Shares after: 0
Date: 13 Jun 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 4,173
Exercise price: $71.84
Footnotes: F8, F10

HSKA transaction Derivative

Non-Qualified Stock Option (right to buy)

Disposed to Issuer

Transaction value
Shares: -7,827
Change %: -100%
Price
Shares after: 0
Date: 13 Jun 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,827
Exercise price: $71.84
Footnotes: F8, F10

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Christopher D. Sveen is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 10 footnotes

Footnote F1

Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of March 31, 2023, by and among the Issuer, Antech Diagnostics, Inc., a California corporation ("Acquiror"), Helsinki Merger Sub LLC, a Delaware limited liability company and a wholly-owned subsidiary of Acquiror, and, solely for purposes of Section 9.15 of the Merger Agreement, Mars, Incorporated, a Delaware corporation, these shares of performance-based restricted stock of the Issuer were fully accelerated assuming maximum level of performance immediately prior to the effectiveness of the merger.

Footnote F2

Pursuant to the Merger Agreement, these performance-based restricted stock units were fully accelerated assuming target level of performance immediately prior to the effectiveness of the merger.

Footnote F3

Disposed of pursuant to the Merger Agreement in exchange for cash consideration of $120.00 per share of common stock of the Issuer (the "Merger Consideration") on the effective date of the merger.

Footnote F4

Pursuant to the Merger Agreement, these performance shares of the Issuer were fully accelerated assuming maximum level of performance immediately prior to the effectiveness of the merger and canceled in the merger in exchange for an amount in cash equal to $120.00 per share.

Footnote F5

1,500 performance shares previously vested and settled.

Footnote F6

Stock options of the Issuer became vested and exercisable upon achieving performance vesting conditions on February 28, 2022.

Footnote F7

Pursuant to the Merger Agreement, these stock options of the Issuer were fully accelerated assuming maximum level of performance immediately prior to the effectiveness of the merger.

Footnote F8

Stock options of the Issuer were canceled in the merger in exchange for an amount in cash equal to the difference, if any, between the Merger Consideration and the exercise price of such stock options.

Footnote F9

These stock options of the Issuer vested in two equal installments on December 31, 2021 and on December 31, 2022.

Footnote F10

These stock options of the Issuer vested in three equal installments on September 24, 2020, September 24, 2021 and September 24, 2022.